
Two hundred and two patients with zzso arthritis zzso starting treatment with large doses of zzso zzso 300 zzso between 1964 and 1974 were followed up until March zzso All but one patient zzso were traced from either hospital or general practice zzso and death zzso where relevant, were zzso A comparison group of 202 patients with zzso not treated with zzso was selected from the diagnostic index of another rheumatology unit and followed up in 1985 to assess their status zzso at March zzso Each patient treated with zzso was matched for year of birth, year of diagnosis, sex, and zzso with a control patient from the latter zzso Four zzso zzso occurred in the zzso treated group compared with two in the control zzso Further analysis of these findings suggested an increased risk of zzso of one case per 1000 patient years of zzso zzso The zzso rates were then compared with those expected based on the zzso in the general zzso This comparison suggested a fivefold increase in the zzso control group and a zzso increase in the zzso treated zzso There was also an excess of patients with zzso zzso including one with myeloma in the zzso group (29 v zzso the excess being greater in the group with the longest duration of zzso This significantly increased risk did not, however, persist on matched analysis, was not related to maximum daily dose, and was not site zzso These results from a possibly unique series of patients treated with high dose zzso give some reassurance about the magnitude of the previously zzso zzso risk of such treatment in zzso 

